close

Clinical Trials

1 216 217 218 219 220
Number of results: 4389

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-03-09 Ery-asp®/Graspa® (eryaspase - L-asparaginase loaded erythrocytes)

acute lymphoblastic leukaemia (ALL)

2 Erytech Pharma (France) Cancer - Oncology
2011-03-04 inhaled Bimosiamose

chronic obstructive pulmonary disease (COPD)

2 Revotar (Germany) Respiratory diseases
2011-03-02 AGN-214868 (senrebotase) 2 Allergan (USA) Syntaxin (UK) CNS diseases - Urology
2011-03-01 CYT107 (recombinant interleukin-7)

chronically HIV infected persons

2a Cytheris (France) Infectious diseases
2011-02-28 Vidofludimus (4SC-101) inflammatory bowel disease 2a 4SC (Germany) Inflammatory diseases
2011-02-24 TRO40303 acute myocardial infarction 1 Trophos (France) Cardiovascular diseases
2011-02-23 APR-246

refractory hematological malignancies
prostate cancer

1-2 Aprea (Sweden) Cancer - Oncology
2011-02-22 simeprevir (TMC435) hepatitis C virus (HCV) genotype-1 2b Medivir (Sweden) Tibotec (J&J group - USA) Infectious diseases
2011-02-22 blood-based biomarker RA-INF-Dx rheumatoid arthritis TcLand Expression (France) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2011-02-22 RPL554 mild asthma Verona Pharma (UK) Allergic diseases - Inflammatory diseases - Respiratory diseases
2011-02-21 IPP-204106 cancer 1-2a Immupharma (UK) Cancer - Oncology
2011-02-21 cell culture-derived, pediatric vaccine to prevent Japanese Encephalitis Japanese Encephalitis 2-3 Intercell (Austria) Infectious diseases
2011-02-18 eliglustat tartrate

Gaucher's disease

2 Genzyme (USA - MA), a Sanofi company (France) Rare diseases - Genetic diseases
2011-02-16 APD421 (intravenous formulation of a currently marketed dopamine D2 antagonist for the new use of prevention and treatment of nausea & vomiting.) chemotherapy-induced nausea & vomiting (CINV) and post-operative nausea and vomiting (PONV) 2a Acacia Pharma (UK) Cancer - Oncology - CNS diseases
2011-02-11 Juvista® (avotermin - human recombinant Transforming Growth Factor Beta3 [TGFBeta3]) type 1 diabetes 3 Renovo (UK) Metabolic diseases
2011-02-10 TMC649128 chronic hepatitis C virus infection 1a Medivir (Sweden) Infectious diseases
2011-02-08 Sitavir® (acyclovir Lauriad™)

herpes labialis

epidemiological study BioAlliance Pharma (France) Infectious diseases
2011-02-08 Avastin® (bevacizumab) reduction of cancer pain 3 Roche (Switzerland) Cancer - Oncology - CNS diseases
2011-02-07 THR-100 (Staphylokinase) acute myocardial infarction 3 ThromboGenics (Belgium) Bharat Biotech International (India) Cardiovascular diseases
2011-02-07 zibotentan non-metastatic castrate resistant prostate cancer (CRPC) 3 AstraZeneca (UK) Cancer - Oncology